All In Biotech

Drug Trial Radar · NCT06625177

A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With Vitiligo

A Phase 1b, Open-Label Trial to Assess Safety and Exploratory Efficacy of TEV-53408 in Participants With Vitiligo

Last checked: Nov 19, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

66

Planned (sponsor's estimate)

Start

Nov 11, 2024

Primary completion

Apr 26, 2028

Study completion Jan 31, 2029

Sponsor

Sponsor type
Industry
First posted
Oct 3, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the trial is to evaluate the safety of TEV-53408 when given as an under the skin injection to adults with vitiligo. Vitiligo is a condition where patches of skin lose color (pigment) and turn white.

Conditions

  • Vitiligo

Interventions

  • TEV-53408Drug

    TEV-53408 injection administered subcutaneously

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With at Least One Treatment-Emergent Adverse EventTime frame: Up to Week 40
  2. Number of Participants With at Least One Serious Treatment-Emergent Adverse EventTime frame: Up to Week 40
  3. Number of Participants With at Least One Protocol-Defined Adverse Event of Special InterestTime frame: Up to Week 40
  4. Number of Participants With at Least One Treatment-Related Adverse EventTime frame: Up to Week 40
  5. Number of Participants who Discontinued Treatment due to an Adverse EventTime frame: Up to Week 40

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • Scottsdale Clinical Research

    Scottsdale, Arizona · Terminated

  • Burke Pharmaceutical Research

    Hot Springs, Arkansas · Recruiting

  • Center for Dermatology Clinical Research, Inc.

    Fremont, California · Recruiting

  • University of CA Irvine

    Irvine, California · Active not recruiting

  • Pasadena Clinical Trials

    Pasadena, California · Active not recruiting

  • Watson Therapeutics Inc. (WTI), USA

    Miramar, Florida · Recruiting

  • MetroMed Clinical Trials

    Chicago, Illinois · Active not recruiting

  • DS Research of Kentucky

    Louisville, Kentucky · Recruiting

  • Hamzavi Dermatology

    Canton, Michigan · Recruiting

  • Oregon Dermatology and Research Center

    Portland, Oregon · Recruiting

  • Dermatology Treatment & Research Center

    Dallas, Texas · Recruiting

  • Center for Clinical Studies, LTD. LLP

    Webster, Texas · Active not recruiting

  • Jordan Valley Dermatology

    South Jordan, Utah · Active not recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.